This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Consejo Superior De Investigaciones Cientificas, Fundacion Imabis. Instituto Mediterraneo Para El Avance De La Biotecnologia Y La Investigacion Sanitaria. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Carolina Cano Ramos: Innovator in Acyclic Sulfamide Derivatives
Introduction
Carolina Cano Ramos is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of biomedicine through her innovative research and development of acyclic sulfamide derivatives. Her work focuses on creating solutions for health-related issues, particularly in the areas of satiety induction and metabolic regulation.
Latest Patents
Carolina holds 1 patent for her invention titled "Acyclic sulfamide derivatives." This invention is related to compounds that are useful for manufacturing medications aimed at inducing satiety, controlling ingestion, modulating body fat, and regulating lipid metabolism. Additionally, these derivatives have potential applications in treating or preventing diabetes and cardiovascular diseases. They are also noted for their usefulness in cosmetic applications.
Career Highlights
Throughout her career, Carolina has worked with several esteemed organizations, including Fundación IMABIS, Instituto Mediterráneo para el Avance de la Biotecnología y la Investigación Sanitaria, and Consejo Superior de Investigaciones Científicas. Her experience in these institutions has allowed her to advance her research and contribute to significant scientific advancements.
Collaborations
Carolina has collaborated with notable professionals in her field, including Fernando Antonio Rodriguez De Fonseca and Manuel Macias Gonzalez. These partnerships have enriched her research and expanded the impact of her innovations.
Conclusion
Carolina Cano Ramos is a trailblazer in the development of acyclic sulfamide derivatives, contributing valuable solutions to health and cosmetic industries. Her work exemplifies the importance of innovation in addressing critical health challenges.